Nearly a fifth of patients exited the survodutide trial due to adverse gastrointestinal events such as nausea, vomiting and ...

By Bhanvi Satija and Stine Jacobsen COPENHAGEN, June 8 (Reuters) - Zealand Pharma's shares tumbled as much as 25% on Monday after trial data for its injectable obesity drug survodutide showed high ...

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) on Tuesday announced the primary analysis of its clinical trial evaluating Berubicin for recurrent or progressive Glioblastoma Multiforme (GBM), an aggressive ...

Silo Pharma, Inc. announced encouraging preliminary results from an ongoing study of its SP-26 ketamine extended-release rods, which are being evaluated for safety and pharmacokinetics after being ...

Big Pharma is hiding a massive secret about so-called miracle weight-loss drugs like Ozempic – they come with a raft of potentially devastating side effects and can also trap users on an endless merry ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

Image above: Old ads provide side effects info against slice-of-life vignettes, a distracting no-no according to new rules. Fox News used to call itself “fair and balanced,” whether or not the network ...

June 5 (Reuters) - Zealand Pharma said on Friday its experimental obesity drug, co-developed with Swiss partner Roche, showed encouraging tolerability in a mid-stage trial, bolstering its push to take ...